NTRB
HEALTHCARENutriband Inc
$3.97-0.11 (-2.70%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving NTRB Today?
No stock-specific AI insight has been generated for NTRB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.42$11.68
$3.97
Fundamentals
Market Cap$48M
P/E Ratio—
EPS$-2.58
Dividend Yield—
Dividend / Share—
ROE-1.4%
Profit Margin—
Debt / Equity—
Trading
Volume14K
Avg Volume (10D)—
Shares Outstanding12.2M
NTRB News
20 articles- Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel PodcastYahoo Finance·Apr 22, 2026
- Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl PatchYahoo Finance·Mar 30, 2026
- Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa RicaYahoo Finance·Mar 18, 2026
- Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa RicaYahoo Finance·Feb 17, 2026
- Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion PointsYahoo Finance·Jan 30, 2026
- The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitableYahoo Finance·Jan 29, 2026
- Nutriband says ‘committed’ to shareholder value as ‘number one focus’Yahoo Finance·Jan 1, 2026
- Nutriband CEO Publishes Letter to ShareholdersYahoo Finance·Dec 31, 2025
- Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision BioYahoo Finance·Dec 29, 2025
- Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic ExplorationYahoo Finance·Dec 18, 2025
- Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass DestructionYahoo Finance·Dec 18, 2025
- Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity ConferenceYahoo Finance·Nov 24, 2025
- MediWound (MDWD) Reports Q3 Loss, Misses Revenue EstimatesYahoo Finance·Nov 20, 2025
- TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue EstimatesYahoo Finance·Nov 13, 2025
- Korro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue EstimatesYahoo Finance·Nov 12, 2025
- Metagenomi (MGX) Reports Q3 Loss, Lags Revenue EstimatesYahoo Finance·Nov 11, 2025
- Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass EstimatesYahoo Finance·Nov 10, 2025
- REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl PatchYahoo Finance·Oct 28, 2025
- Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl PatchYahoo Finance·Oct 28, 2025
- Nutriband Co-Founder Gareth Sheridan Returns as CEOYahoo Finance·Oct 27, 2025
All 20 articles loaded
Price Data
Open$4.09
Previous Close$4.08
Day High$4.18
Day Low$3.93
52 Week High$11.68
52 Week Low$3.42
52-Week Range
$3.42$11.68
$3.97
Fundamentals
Market Cap$48M
P/E Ratio—
EPS$-2.58
Dividend Yield—
Dividend / Share—
ROE-1.4%
Profit Margin—
Debt / Equity—
Trading
Volume14K
Avg Volume (10D)—
Shares Outstanding12.2M
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—